BrewDog Bars Draw Record Fan Turnout as Global Tournament Fever Drives Double-Digit Growth

BrewDog bars across the UK achieved record fan attendance and double-digit sales growth during the 2026 FIFA World Cup, driven by packed venues, strong food and beverage sales, and increased demand for premium craft beers. American craft beer brands including SweetWater, Montauk, and Blue Point sold through initial inventory within the first week, prompting immediate reorders. BrewDog's flagship Punk IPA remained among top-selling beers, while the bars served as popular gathering destinations offering live sports viewing, air conditioning, and community experiences.

06/22/2026, 9:50 AM • GlobeNewswire

Is Now a Good Time to Buy Tilray Brands Stock?

Tilray Brands has pivoted from a struggling cannabis company to a diversified consumer packaged goods company with operations in cannabis, beverages, and hemp-based foods, including the acquisition of BrewDog. While the company achieved record revenues with 11% organic growth in Q3 2026, it has never reported positive earnings as a public company. The article suggests aggressive growth investors may find opportunity in the repositioning, but most investors should wait for proof of sustainable profitability before investing.

06/21/2026, 5:15 PM • The Motley Fool

Hi*Ball Energy fait son entrée au Royaume-Uni et redéfinit les codes de la boisson énergisante

Hi*Ball Energy, a sugar-free sparkling energy water brand owned by Tilray Brands, officially launched in the UK on June 18, 2026. The beverage contains natural caffeine, B vitamins, guarana, and ginseng with zero calories and no artificial sweeteners. Available through Amazon UK and BrewDog.com in four flavors at £1.90 per 330ml can, the product targets health-conscious consumers seeking alternatives to traditional energy drinks. The launch coincides with the Barcode Festival and precedes broader European and international expansion.

06/18/2026, 5:56 PM • GlobeNewswire

Hi*Ball Energy erobert Großbritannien und wird zum Vorreiter des neuen „Clean Energy“-Trends

Hi*Ball Energy, a sparkling energy water brand owned by Tilray Brands, officially launched in the United Kingdom on June 18, 2026. The product contains 100mg of natural caffeine, B-vitamins, guarana, and ginseng with zero sugar, calories, and artificial sweeteners. Available through Amazon UK and BrewDog.com at £1.90 per 330ml can, Hi*Ball targets health-conscious consumers seeking alternatives to traditional energy drinks. The brand will debut at the Barcode Festival on July 2 and plans expansion into European, Middle Eastern, African, and Asia-Pacific markets.

06/18/2026, 5:56 PM • GlobeNewswire

Breckenridge Brewery Launches a Colorado-Wide Soccer Celebration with Fan-First Activations

Breckenridge Brewery, a Colorado craft beer brand owned by Tilray Brands, is launching a summer-long series of watch parties, competitions, and limited-release beers across its taprooms and partner locations to capitalize on international soccer tournament excitement. The campaign includes foosball competitions, trivia nights, themed merchandise, and match-day specials designed to drive foot traffic and community engagement.

06/16/2026, 7:00 AM • GlobeNewswire

Tilray Is Growing 73% Internationally. The Market Is Paying Almost No Attention. Is That a Mistake?

Tilray reported 73% international cannabis revenue growth in Q3 2026, but this represents only $24 million of the company's $206.7 million total sales. While the company is undergoing a strategic transformation from a pure marijuana play to a diversified consumer packaged goods company (including alcohol), it continues to lose money and faces headwinds including a 24% beverage sales decline and 20% U.S. operations decline. The stock remains a high-risk investment suitable only for aggressive investors until profitability is achieved.

06/14/2026, 1:15 PM • The Motley Fool

The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here's What That Means for Every Cannabis Investor.

Trulieve Cannabis became the first U.S. cannabis operator to list on the NYSE after the federal government reclassified medical marijuana to Schedule III. This milestone could open doors for institutional investors and improve market access for the cannabis industry, though significant challenges including debt, market saturation, and regulatory uncertainty remain.

06/14/2026, 6:15 AM • The Motley Fool

Tilray Medical Allemagne lance ARX™, une nouvelle marque de cannabis médicinal haut de gamme cultivé en Allemagne

Tilray Medical Germany has launched ARX™, a premium medical cannabis brand cultivated locally in Germany at its Aphria RX facility in Neumünster. The brand combines Broken Coast genetics with German cultivation expertise and strict European GMP standards, marking Tilray's first locally-developed premium medical cannabis brand in Germany. The product will be officially presented at Mary Jane Berlin 2026 and distributed nationally through CC Pharma and 14U Pharma.

06/10/2026, 8:30 PM • GlobeNewswire

Tilray Medical Deutschland bringt ARX™ auf den Markt, eine neue Premium-Marke für medizinisches Cannabis aus deutschem Anbau

Tilray Medical Deutschland hat die Markteinführung von ARX™ angekündigt, einer neuen Premium-Marke für medizinisches Cannabis, die im Aphria RX-Werk in Neumünster entwickelt und angebaut wird. Die Marke kombiniert bewährte Genetik von Broken Coast mit deutschem Anbauknow-how und wird nach EU-GMP-Standards hergestellt. ARX wird auf der Mary Jane Berlin 2026 vorgestellt und über etablierte deutsche Vertriebskanäle wie CC Pharma und 14U Pharma vertrieben.

06/10/2026, 8:30 PM • GlobeNewswire

Trulieve Makes History As First US Cannabis Stock On NYSE

Trulieve Cannabis Corp. became the first U.S. cannabis company to list on a major U.S. stock exchange (NYSE: TRLV), enabled by the Trump administration's reclassification of cannabis to Schedule III. The company separated its medical and adult-use operations to meet exchange requirements. Competitors like Curaleaf and Verano are preparing for similar uplistings, while Canadian producers remain on Nasdaq. The listing has energized the cannabis sector.

06/10/2026, 5:25 PM • Benzinga

Is Tilray's Brewdog Bet Already Backfiring? Collapsing UK Sales Suggest Yes.

Tilray acquired UK craft brewer Brewdog for approximately $44 million as part of its pivot from marijuana to brand management. However, Brewdog's UK sales have declined 22.5% since the sale process began, with accelerating downward trends. While Tilray selectively acquired only certain Brewdog locations and brands, the weak performance raises concerns about the acquisition's timing and potential challenges during integration.

06/07/2026, 8:15 PM • The Motley Fool

Glioblastoma Multiforme Market Poised for Significant Growth at a CAGR of 13.2% During the Forecast Period (2026–2036), as Next-Generation Therapies Enter Late-Stage Development | DelveInsight

The glioblastoma multiforme market is expected to grow at a CAGR of 13.2% from 2026-2036, driven by next-generation therapies entering late-stage development. The market was valued at USD 900 million in 2025 across the 7MM, with approximately 38,000 incident cases. Key players including Avita Biomedical, Kazia Therapeutics, Laminar Pharma, and others are advancing innovative immunotherapies, targeted treatments, and personalized medicine approaches to address the poor prognosis of this aggressive brain tumor.

05/27/2026, 1:00 PM • GlobeNewswire

BrewDog Turns This Summer’s Global Football Tournament into a Nationwide Celebration of Beer, Bars and Big Match Moments

BrewDog, part of Tilray Brands, is launching a major summer campaign centered around international football, featuring a nationwide 'Win a Year of Beer' promotion with 2.8 million promotional packs across U.K. retailers, destination match-day watch parties at BrewDog bars, and multi-channel activations across retail, e-commerce, and digital platforms.

05/27/2026, 7:00 AM • GlobeNewswire

Tilray Looks Ready for a Breakout -- If 1 Thing Goes Right

Tilray Brands has improved its fundamentals with stronger international cannabis sales (73% YoY growth) and reduced net losses, but the stock's breakout potential remains heavily dependent on U.S. cannabis rescheduling and legalization. While the company shows operational progress, other cannabis stocks with broader catalysts may offer better opportunities.

05/27/2026, 1:30 AM • The Motley Fool

Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now

Canopy Growth announced it will restate financial results for two years due to a technical accounting error involving share-settled warrants that should have been classified as liabilities rather than equity. The company states the restatement won't impact revenue, operating income, cash flows, or key performance metrics. However, the stock remains a risky penny stock in a struggling marijuana sector facing intense competition and illicit market pressures. Most investors should avoid the stock until it achieves sustainable profitability and the restatement is complete.

05/22/2026, 11:15 PM • The Motley Fool